Table.

Laboratory Data on Admission.

White cell count	2,710	/μL	PT	14.2	s
Differential count			APTT	38.9	s
Polymorphonuclear cells	84.8	%	FDP	262.8	μg/mL
Lymphocytes	10.7	%	Fibrinogen	494	mg/dL
Monocytes	3	%	D-dimer	156.8	μg/mL
Basophils	1.1	%	CEA	75.6	ng/mL
Eosinophils	0.4	%	SLX	40	U/mL
Hemoglobin	12.0	g/dL	Rheumatoid factor	236	U/mL
MCV	96.9	fL	Anti-HCV antibody	Negative
Reticulocyte	1.1	%	HBs antigen	Negative
Platelets	134,000	/μL	Anti-HBs antibody	2.0	U/mL
AST	84	U/L	Anti-nuclear antibodies
ALT	13	U/L	Homogenous pattern	40	×
LDH	614	U/L	Speckled pattern	40	×
ALP	199	U/L	MMP-3	113	ng/mL
Total protein	6.2	g/dL	Anti-CCP antibody	387	U/mL
Albumin	2.9	g/dL	IGRA	Negative
Sodium	127	mmol/L	Anti-VZV antibodies
Potassium	4.4	mmol/L	IgG	12.1	×
Chloride	95	mmol/L	IgM	0.04	×
BUN	17	mg/dL	Anti-HSV antibodies
Creatinin	0.82	mg/dL	IgG	0.8	×
HDL-C	33	mg/dL	IgM	0.04	×
LDL-C	79	mg/dL	CMV antigen (C10, C11)	Negative
Triglyceride	88	mg/dL	Anti-EBV antibodies
Hemoglobin A1c	5.8	%	IgG	160	×
Haptoglobin	236.0	mg/dL	VCA-IgM	Negative
CRP	8.05	mg/dL	EA-DR-IgG	Negative
sIL-2R	4,625	U/mL	EBNA-IgG	80	×
Iron	44	μg/dL	Anti-HHV-6 antibodies
TIBC	217	μg/dL	IgG	80	×
Ferritin	28,976	ng/mL	IgM	Negative

ALT: alanine aminotransferase, ALP: alkaline phosphatase, APTT: activated partial thromboplastin time, AST: aspartate aminotransferase, BUN: blood urea nitrogen, CCP: cyclic citrullinated protein, CEA: carcinoembryonic antigen, CMV: cytomegalovirus, CRP: C-reactive protein, EBV: Epstein-Barr virus, FDP: fibrin degradation products, HBs: hepatitis B surface, HCV: hepatitis C virus, HDL-C: high density lipoprotein cholesterol, HHV-6: human herpesvirus-6, HSV: herpes simplex virus, IGRA: interferon-gamma release assay, LDH: lactate dehydrogenase, LDL-C: low density lipoprotein cholesterol, MCV: mean corpuscular volume, MMP-3: matrix metalloprotease-3, PT: prothrombin time, sIL-2R: soluble interleukin-2 receptor, SLX: sialyl SSEA-1, TIBC: total iron binding capacity, VZV: varicella-zoster virus